Crossmark

Targeting hepatic sulfane sulfur/hydrogen sulfide signaling pathway with α-lipoic acid to prevent diabetes-induced liver injury via upregulating hepatic CSE/3-MST expression

Crossref DOI link: https://doi.org/10.1186/s13098-022-00921-x

Published Online: 2022-10-13

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dugbartey, George J.

Alornyo, Karl K.

Adams, Ismaila

Atule, Stephen

Obeng-Kyeremeh, Richard

Amoah, Daniel

Adjei, Samuel
Funding

Funding for this research was provided by:

Carnegie Corporation of New York (UG-BA/PD-015/2017-2018, UG-BA/PD-015/2017-2018, UG-BA/PD-015/2017-2018, UG-BA/PD-015/2017-2018, UG-BA/PD-015/2017-2018, UG-BA/PD-015/2017-2018, UG-BA/PD-015/2017-2018)
License Information

Text and Data Mining valid from 2022-10-13

Version of Record valid from 2022-10-13
More Information

Article History

Received: 3 August 2022

Accepted: 5 October 2022

First Online: 13 October 2022

Declarations

:

: All experiments involving animals were reviewed and approved by the University of Ghana Institutional Animal Care and Use Committee (Protocol ID: UG-IACUC 002/19-20).

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below